Marc Tischkowitz
From Wikipedia, the free encyclopedia
King's College London GKT School of Medical Education (Ph.D.)
Marc Tischkowitz | |
|---|---|
 | |
| Alma mater | University of Liverpool (MB ChB) King's College London GKT School of Medical Education (Ph.D.) |
| Known for | Hereditary cancer research, genomic technology |
| Scientific career | |
| Fields | Cancer Genetics, Hereditary Cancer Syndromes |
| Institutions | McGill University Faculty of Medicine School of Clinical Medicine, University of Cambridge |
| Thesis | The role of mutations in fanconi anaemia genes in the aetiology of acute myeloid leukaemia and solid tissue malignancies (2003) |
| Website | https://medgen.medschl.cam.ac.uk/dr-marc-tischkowitz-2/ |
Marc Tischkowitz is a British medical geneticist. He is a Professor and Head of the Department of Genomic Medicine at University of Cambridge. He also works as an Honorary NHS Consultant in the East Genomic Medicine Service. He is editor-in-chief of BJC Reports. Tischkowitz researches Fanconi Anemia genes, hereditary cancer syndromes, and genomic technologies.
Tischkowitz completed a Bachelor of Medicine, Bachelor of Surgery at University of Liverpool in 1993. He undertook residencies in Medical Oncology and Clinical Genetics, obtaining a Certificate of Completion of Specialist Training in Clinical Genetics. In 1999, he began doctoral studies researching chromosome breakage syndrome, fanconi anemia, gene mutations, and acute myeloid leukemia.[1][2] He earned a Ph.D. from King's College, London.[1][3] His 2003 dissertation was titled The role of mutations in Fanconi Anaemia genes in the aetiology of acute myeloid leukaemia and solid tissue malignancies.[3]
